New diabetes combo pill shows promise in phase 3 trial
NCT ID NCT05814406
First seen Nov 01, 2025 · Last updated May 24, 2026 · Updated 26 times
Summary
This study tested whether adding the drug JW0201 to two other diabetes medications helps lower blood sugar in people with type 2 diabetes. 196 adults whose blood sugar was not well controlled on their current treatment took part. The main goal was to see if JW0201 reduced HbA1c levels over 24 weeks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chosun University Hospital
Gwangju, 61452, South Korea
Conditions
Explore the condition pages connected to this study.